A Study of Bomedemstat (MK-3543) in Participants with Polycythemia Vera (MK-3543-004)

Trial Identifier: 3543-004
Sponsor: Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
Start Date: September 2023
Primary Completion Date: March 2025
Study Completion Date: July 2025
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Protocol Plain Language Summary - English

Trial Locations

Country Location
Australia, Queensland Sunshine Coast, Queensland, Australia, 4556
Australia, Victoria Clayton, Victoria, Australia, 3168
Australia, Western Australia Perth, Western Australia, Australia, 6000
United Kingdom, England Gloucester, England, United Kingdom, GL1 3NN
United Kingdom, Great Britain Lincoln, Great Britain, United Kingdom, LN2 5QY
United Kingdom, Great Britain London, Great Britain, United Kingdom, W12 0HS
United Kingdom, Lincolnshire Boston, Lincolnshire, United Kingdom, PE21 9QS
United Kingdom, London, City of London, London, City of, United Kingdom, SE1 9RT
United Kingdom, Wales Newport, Wales, United Kingdom, NP9 2UB
United States, FL Plantation, FL, United States, 33322
United States, IL Skokie, IL, United States, 60076-1264
United States, MI Ann Arbor, MI, United States, 48109
United States, NC Durham, NC, United States, 27705
United States, NV Las Vegas, NV, United States, 89128
United States, OH Columbus, OH, United States, 43203
United States, OR Portland, OR, United States, 97239-4503
United States, UT Salt Lake City, UT, United States, 84112